Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony J Coyle

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoproteinNadege Goutagny, Zhaozhao Jiang, Jane Tian, et al.
European Journal of Immunology|April 29, 2004
ICOS-mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cellsPedro L Vieira, Lianne Wassink, L Mary Smith, et al.
American Journal of Respiratory Cell and Molecular Biology|October 3, 2002
Granulocyte macrophage colony-stimulating factor-driven respiratory mucosal sensitization induces Th2 differentiation and function independently of interleukin-4Stacey A Ritz, Meghan J Cundall, Beata U Gajewska, et al.
American Journal of Respiratory and Critical Care Medicine|February 6, 2010
Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary diseaseNassima Ferhani, Séverine Letuve, Alexander Kozhich, et al.
British Journal of Haematology|September 10, 2011
A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivoElizabeth Ward, Nanette Mittereder, Ellen Kuta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasmsWilliam J Simmons, Mythili Koneru, Mani Mohindru, et al.
The Journal of Experimental Medicine|December 4, 2002
Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritisEthan P Grant, Dominic Picarella, Timothy Burwell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functionsDuncan Howie, F Stephen Laroux, Massimo Morra, et al.
Nature Immunology|October 14, 2003
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral toleranceCatherine A Sabatos, Sumone Chakravarti, Eugene Cha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13Svetlana P Chapoval, Amal Al-Garawi, Jose M Lora, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoproteinNadege Goutagny, Zhaozhao Jiang, Jane Tian, et al.
European Journal of Immunology|April 29, 2004
ICOS-mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cellsPedro L Vieira, Lianne Wassink, L Mary Smith, et al.
American Journal of Respiratory Cell and Molecular Biology|October 3, 2002
Granulocyte macrophage colony-stimulating factor-driven respiratory mucosal sensitization induces Th2 differentiation and function independently of interleukin-4Stacey A Ritz, Meghan J Cundall, Beata U Gajewska, et al.
American Journal of Respiratory and Critical Care Medicine|February 6, 2010
Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary diseaseNassima Ferhani, Séverine Letuve, Alexander Kozhich, et al.
British Journal of Haematology|September 10, 2011
A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivoElizabeth Ward, Nanette Mittereder, Ellen Kuta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasmsWilliam J Simmons, Mythili Koneru, Mani Mohindru, et al.
The Journal of Experimental Medicine|December 4, 2002
Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritisEthan P Grant, Dominic Picarella, Timothy Burwell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functionsDuncan Howie, F Stephen Laroux, Massimo Morra, et al.
Nature Immunology|October 14, 2003
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral toleranceCatherine A Sabatos, Sumone Chakravarti, Eugene Cha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13Svetlana P Chapoval, Amal Al-Garawi, Jose M Lora, et al.
Pageof 13